TM4SF1 and cancer: In the advanced clinical stage, a progenitor‐like, TM4SF1‐positive cancer cell subpopulation emerges in MIBC driven by BMP signaling and EMT, which contributes to ITH by supporting highly plastic transcriptional phenotypes with its unique epigenome.